In Vitro Metabolism of the Novel, Highly Selective Oral Angiogenesis Inhibitor Motesanib Diphosphate in Preclinical Species and in Humans

Chun Li(University of Southern California), Sekhar Surapaneni(Bristol-Myers Squibb (United States)), Mita Kuchimanchi, Leszek Poppe, Yihong Zhou(Soochow University), Dean Hickman, Raju Subramanian(Gilead Sciences (United States)), Mike Hayashi, Gondi Kumar
Drug Metabolism and Disposition
April 17, 2009
Cited by 15


Related Papers